Uni Biotech Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.10 M
- Revenue Growth 25.79%
- Profit Growth 691.30%
- Ebitda 3.34%
- Net Worth 27.03%
- Total Assets 13.05%
About Uni Biotech Healthcare
Uni Biotech Healthcare Private Limited (UBHPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 November 2011 and has a history of 13 years and three months. Its registered office is in Ambala, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.10 M.
Anil Rana and Reema serve as directors at the Company.
Company Details
- Location
Ambala, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232HR2011PTC044261
- Company No.
044261
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Nov 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Uni Biotech Healthcare Private Limited offer?
Uni Biotech Healthcare Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antacid Drugs, Common Disease Medicines, Pharmaceutical Tablets, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Vitamin Tablets & Capsules, Dietary Supplements, Pre & Probiotic Capsule, Anti Infective Drugs & Medicines.
Who are the key members and board of directors at Uni Biotech Healthcare?
Financial Performance of Uni Biotech Healthcare.
Uni Biotech Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 25.79% increase. The company also saw a substantial improvement in profitability, with a 691.3% increase in profit. The company's net worth Soared by an impressive increase of 27.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Uni Biotech Healthcare?
In 2019, Uni Biotech Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.10 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.21 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Feb 2023 | Hdfc Bank Limited | ₹2.10 M | Open |
How Many Employees Work at Uni Biotech Healthcare?
Unlock and access historical data on people associated with Uni Biotech Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Uni Biotech Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uni Biotech Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
